Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea · Delayed Price · Currency is KRW 7,710.00
-100.00 (-1.28%)
At close: Aug 21, 2026
Daewon Pharmaceutical Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 614,636 | 605,435 | 598,162 | 526,952 | 478,885 | 354,176 |
Revenue Growth | 1.83% | 1.22% | 13.51% | 10.04% | 35.21% | 14.81% |
Gross Profit Gross Profit Growth | 279,555 | 271,416 | 285,974 | 255,144 | 235,847 | 174,546 |
Operating Income Operating Income Growth | -87.95 | 3,484 | 26,677 | 32,233 | 42,904 | 19,303 |
Net Income Net Income Growth | 2,632 | -1,380 | 14,210 | 23,917 | 31,944 | 6,989 |
Earnings Per Share EPS Growth | 99.57 | -87.38 | 667.43 | 1110.44 | 1478.37 | 329.36 |
EPS Growth | -73.80% | - | -39.90% | -24.89% | 348.86% | -60.15% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Restrictions Restrictions Growth | 542,981 | 536,086 | 500,696 | 452,801 | 339,076 |
Cosmetics Cosmetics Growth | 30,069 | 34,471 | - | - | - |
Health Functional Food Health Functional Food Growth | 36,071 | 28,059 | 26,482 | 25,864 | 13,067 |
Other Sectors Other Sectors Growth | 481.72 | 504.2 | - | - | - |
Consolidated Adjustments Consolidated Adjustments Growth | -4,168 | -958.6 | -521.2 | -1,067 | -155.22 |
Total Total Growth | 605,435 | 598,162 | 526,952 | 478,885 | 354,176 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 66,185 | 76,475 | 46,108 | 30,030 | 47,006 | 54,820 |
Total Debt Total Debt Growth | 189,151 | 202,034 | 187,241 | 146,050 | 116,476 | 123,968 |
Net Cash (Debt) Net Cash Growth | -122,966 | -125,559 | -141,133 | -116,020 | -69,471 | -69,148 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -5724.48 | -5858.09 | -6629.05 | -5356.37 | -3175.72 | -3258.76 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 18,182 | 42,313 | 30,035 | 51,734 | 26,413 | 22,413 |
Capital Expenditures CapEx Growth | -23,354 | -29,801 | -34,864 | -12,289 | -8,009 | -4,104 |
Free Cash Flow Free Cash Flow Growth | -5,172 | 12,512 | -4,829 | 39,446 | 18,405 | 18,309 |
Free Cash Flow Growth | - | - | - | 114.32% | 0.52% | 34.58% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 45.48% | 44.83% | 47.81% | 48.42% | 49.25% | 49.28% |
Operating Margin | -0.01% | 0.58% | 4.46% | 6.12% | 8.96% | 5.45% |
Pretax Margin | 1.47% | 0.42% | 2.70% | 4.90% | 8.09% | 4.84% |
Profit Margin | 0.43% | -0.23% | 2.38% | 4.54% | 6.67% | 1.97% |
FCF Margin | -0.84% | 2.07% | -0.81% | 7.49% | 3.84% | 5.17% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 250.000 | 250.000 | - | - | - | 194.175 |
Dividend Per Share Growth | -16.67% | - | - | - | - | 25.00% |
Dividend Yield | 3.22% | 2.09% | - | - | - | 1.30% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 39.94 | - | 21.49 | 13.88 | 12.31 | 49.08 |
Forward PE | 7.35 | 73.09 | 8.31 | 9.94 | 11.36 | 16.53 |
P/FCF Ratio | - | 20.47 | - | 8.41 | 21.36 | 18.73 |
PS Ratio | 0.27 | 0.42 | 0.51 | 0.63 | 0.82 | 0.97 |